iCo Therapeutics Inc (CVE:ICO)’s share price was down 14.3% during trading on Friday . The stock traded as low as C$0.06 and last traded at C$0.06, approximately 1,231,866 shares were traded during trading. An increase of 495% from the average daily volume of 206,891 shares. The stock had previously closed at C$0.07.
The stock has a market capitalization of $9.23 million and a price-to-earnings ratio of -4.29. The company’s 50-day simple moving average is C$0.07 and its 200 day simple moving average is C$0.08.
About iCo Therapeutics (CVE:ICO)
iCo Therapeutics Inc, a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat sight and life threatening diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat sight threatening ocular allergies and various systemic disease indications; and Oral AmpB Delivery System that is in pre-clinical stage used for the treatment of systemic fungal infections.
See Also: Relative Strength Index
Receive News & Ratings for iCo Therapeutics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for iCo Therapeutics and related companies with MarketBeat.com’s FREE daily email newsletter.